JP2015520165A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520165A5
JP2015520165A5 JP2015512903A JP2015512903A JP2015520165A5 JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5 JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5
Authority
JP
Japan
Prior art keywords
salt
compound
formula
process according
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512903A
Other languages
English (en)
Japanese (ja)
Other versions
JP6196294B2 (ja
JP2015520165A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041687 external-priority patent/WO2013173779A1/en
Publication of JP2015520165A publication Critical patent/JP2015520165A/ja
Publication of JP2015520165A5 publication Critical patent/JP2015520165A5/ja
Application granted granted Critical
Publication of JP6196294B2 publication Critical patent/JP6196294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512903A 2012-05-17 2013-05-17 アミノ酸化合物を製造するためのプロセス Active JP6196294B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261648534P 2012-05-17 2012-05-17
US61/648,534 2012-05-17
PCT/US2013/041687 WO2013173779A1 (en) 2012-05-17 2013-05-17 Process for making amino acid compounds

Publications (3)

Publication Number Publication Date
JP2015520165A JP2015520165A (ja) 2015-07-16
JP2015520165A5 true JP2015520165A5 (https=) 2016-06-30
JP6196294B2 JP6196294B2 (ja) 2017-09-13

Family

ID=48483247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512903A Active JP6196294B2 (ja) 2012-05-17 2013-05-17 アミノ酸化合物を製造するためのプロセス

Country Status (21)

Country Link
US (1) US9278917B2 (https=)
EP (1) EP2850054B1 (https=)
JP (1) JP6196294B2 (https=)
KR (1) KR102074535B1 (https=)
CN (1) CN104520263B (https=)
AU (1) AU2013262516B2 (https=)
BR (1) BR112014028585B1 (https=)
CA (1) CA2873658C (https=)
ES (1) ES2668477T3 (https=)
HR (1) HRP20180948T1 (https=)
IL (1) IL235630A (https=)
MA (1) MA37751B1 (https=)
MX (1) MX350443B (https=)
MY (1) MY171538A (https=)
NZ (1) NZ702939A (https=)
PL (1) PL2850054T3 (https=)
RU (1) RU2643146C2 (https=)
SG (1) SG11201407625WA (https=)
SI (1) SI2850054T1 (https=)
TR (1) TR201807444T4 (https=)
WO (1) WO2013173779A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
HRP20200992T1 (hr) 2012-05-17 2020-10-16 Genentech, Inc. Amorfni oblik pirimidinil-ciklopentanskog spoja koji inhibira akt, te njegovi pripravci i postupci
RU2014151017A (ru) 2012-05-17 2016-07-10 Аррэй Байофарма Инк. Способ получения гидроксилированных циклопентилпиримидинов
AU2013262505B2 (en) 2012-05-17 2017-09-21 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
ES2765511T3 (es) * 2013-11-15 2020-06-09 Hoffmann La Roche Procesos para la preparación de compuestos de pirimidinilciclopentano
ES2749100T3 (es) * 2014-09-26 2020-03-19 Hoffmann La Roche Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH09506369A (ja) 1993-12-12 1997-06-24 アグロジーン・リミテッド 菌類感染から植物を保護するための新規方法
AU724216B2 (en) 1997-04-07 2000-09-14 Merck & Co., Inc. A method of treating cancer
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
CA2363169A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
JP4550811B2 (ja) 2003-06-09 2010-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング パピローマウイルスのインヒビター
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2209775A1 (en) 2007-10-09 2010-07-28 UCB Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
CN102459165B (zh) 2009-04-15 2015-09-02 Abbvie公司 抗病毒化合物
MX2012004780A (es) 2009-10-23 2012-08-23 Lilly Co Eli Inhibidores de akt.
EP2592933B1 (en) 2010-07-16 2017-04-05 Anderson Gaweco Mif inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
RU2014151017A (ru) 2012-05-17 2016-07-10 Аррэй Байофарма Инк. Способ получения гидроксилированных циклопентилпиримидинов
CN104471070B (zh) 2012-05-17 2018-09-25 基因泰克公司 制备羟基化环戊并嘧啶化合物和其盐的方法
WO2014071194A2 (en) 2012-11-01 2014-05-08 Katz Robert S Methods for treating fibromyalgia
WO2014127350A1 (en) 2013-02-18 2014-08-21 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
WO2014150395A1 (en) 2013-03-15 2014-09-25 Shifa Biomedical Corporation Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Similar Documents

Publication Publication Date Title
JP2015520165A5 (https=)
JP2011057686A5 (https=)
PE20081609A1 (es) Compuestos carboxamida y su uso como inhibidores de calpaina
JP2007269812A5 (https=)
JP2012507568A5 (https=)
JP2011513410A5 (https=)
JP2015518892A5 (https=)
JP2011511933A5 (https=)
JP2011510079A5 (https=)
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
ECSP067077A (es) Derivados de pirrolopiridina y su uso como antagonistas de crth2
RU2711869C3 (ru) Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
JP2009530282A5 (https=)
JP2005053931A5 (https=)
JP2013500304A5 (https=)
JP2014500861A5 (https=)
MX377235B (es) Proceso mejorado para preparar bifenilanilidas y bifenilanilinas cloradas.
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
JP2011522839A5 (https=)
JP2015518837A5 (https=)
AR083105A1 (es) Metodo para preparar 2-amino-n-(2,2,2-trifluoroetil)acetamida
MX2007007098A (es) Derivados de pirrol que tienen actividad antagonista del receptor crth2.
RU2014150991A (ru) Способ получения аминокислотных соединений
JP2007526383A5 (https=)
JP2006518752A5 (https=)